Lido Advisors’s Cellectis CLLS Stock Holding History

Lido Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,094	Closed	-$32K	–	2153
2026 Q1	$32K	Buy	+10,094	New	+$38.7K	﹤0.01%	1916

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Lido Advisors's CLLS Position: Q2 2026 in Review

Lido Advisors sold out of Cellectis (CLLS) in Q2 2026, closing a stake of 10,094 shares — an estimated $32K sold.

Lido Advisors first reported a position in CLLS in Q1 2026 and held it in 1 quarter. The position peaked at $32K in Q1 2026. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

Lido Advisors reported no remaining Cellectis position as of Q2 2026 after selling out during the quarter.
Lido Advisors sold 10,094 Cellectis shares in Q2 2026, an estimated $32K.
Lido Advisors first reported a position in Cellectis in Q1 2026 and held it in 1 quarter.
Lido Advisors's Cellectis position peaked at $32K in Q1 2026.
27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.